BackPear Therapeutics Overview

Pear Therapeutics Total Current Liabilities

Track Pear Therapeutics's total current liabilities ($49M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$49.44M
4.83% YoYΔ $2.28M vs prior year quarter

Peer average

Loading

Pear Therapeutics Total Current Liabilities History

Loading

Pear Therapeutics vs. peers: Total Current Liabilities Comparison

Loading

Pear Therapeutics Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pear Therapeutics (PEAR) FAQ

As of the most recent data (December 2022), PEAR shows a total current liabilities of $49M. That compares with $47M in the prior-year period — up 4.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEAR's total current liabilities is now $49M (was $47M) — a 4.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics is outperforming or lagging.

Tracking PEAR's total current liabilities over time shows whether Pear Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $49M That compares with $47M in the prior-year period — up 4.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Pear Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $49M) with ownership activity and broader fundamentals.